Author Response: Guillain-Barré Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

• Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
• Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
• Submit only on articles published within 6 months of issue date.
• Do not be redundant. Read any comments already posted on the article prior to submission.
• Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates